Lori Kunkel
Director/Board Member at ORIC PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Richard Heyman | M | 66 | 10 years | |
Jacob van Naarden | M | 39 | 10 years | |
Diantha Duvall | F | 52 | 2 years | |
Samuel Kintz | M | 38 | 5 years | |
Jason Daniel Kantor | M | - | 4 years | |
Terrence Connolly | M | - |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | - |
Joseph Lyssikatos | M | 59 | 5 years | |
Jacob Chacko | M | 45 | 6 years | |
Julia Gregory | F | 71 | 5 years | |
Arthur Sands | M | 62 | 10 years | |
Christine Ring | M | 59 | 5 years | |
Mika Derynck | M | 61 | 1 years | |
Anish Patel | M | 43 | 5 years | |
Edward Saltzman | M | 69 | 2 years | |
Robert DuBridge | M | - |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 8 years |
Andrew Phillips | M | 53 | 1 years | |
Paul Silva | M | 58 | 3 years | |
Steven Hoerter | M | 53 | 3 years | |
Judith Reinsdorf | F | 60 | 3 years | |
John Hohneker | M | 64 | 3 years | |
Rishi Gupta | M | 46 | 1 years | |
Mardi Dier | F | 60 | 4 years | |
Angie You | M | 51 | 3 years | |
Jake Bauer | M | 45 | 1 years | |
James Scibetta | M | 59 |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 7 years |
Terry Connolly | F | - |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | 3 years |
Gwenn Hansen | M | 53 | 9 years | |
Galya Blachman | M | 47 | - | |
Paula O’Connor | M | - | 2 years | |
Dora Ferrari | F | - | 3 years | |
Chong Xu | M | 43 |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | - |
Michael Heffernan | M | 59 |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | - |
Kimberly Steinmann | M | - | 2 years | |
William Greene | M | - |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 5 years |
Buckley Kohlhauff | M | - | 3 years | |
Raf Lambrecht | M | - | 4 years | |
Hans van Houte | M | 58 | 9 years | |
Sunitha Ramamurthy | F | - | 6 years | |
Lori Friedman | M | 60 | 5 years | |
Pratik Multani | M | 57 | 6 years | |
Reinhard von Roemeling | M | - | 5 years | |
Jason Rhodes | M | 54 |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | - |
Matthew Panuwat | M | 47 | 6 years | |
Helen Collins | M | 62 | 1 years | |
Dominic Piscitelli | M | 50 | 5 years | |
Christian V. Kuhlen | M | 51 | - | |
Michael T. Lotze | M | - | 4 years | |
Rahul Ballal | M | 46 | 1 years | |
Edna Maneval | M | 64 | 5 years | |
Betty Chang | M | - | 11 years | |
Thorsten Graef | M | - | 11 years | |
Benjamin Hohl | M | 35 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Harry E. Gruber | M | 72 | 13 years | |
Josh Bilenker | M | 52 | 6 years | |
Ali Fattaey | M | 59 | 5 years | |
William Steinkrauss | M | 39 | 6 years | |
Peter Svennilson | M | 62 | 7 years | |
Timothy Kutzkey | M | 49 | 10 years | |
Dennis Berman | M | 73 | 10 years | |
Paul Wagner | M | 53 | - | |
James McNab | M | 80 | 17 years | |
Dov Goldstein | M | 56 | 2 years | |
Arlene Morris | F | 72 | 4 years | |
David Lacey | M | 71 | 8 years | |
Sean P. Lance | M | 77 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 6 years |
Manmeet Singh Soni | M | 46 | 3 years | |
Robert A. Swanson | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
Matthew Outten | M | 49 | 5 years | |
Kenneth J. Pienta | M | 64 | 4 years | |
Jesse Seton McGreivy | M | 54 | - | |
Ingrid Boyes | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
David Tuck | M | 72 | 3 years | |
Jennifer Burstein | F | 52 | 4 years | |
Joshua Brumm | M | 46 | 1 years | |
Hans-Peter Gerber | M | - |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 2 years |
Douglas J. Jolly | M | - | 13 years | |
Stephen Brady | M | 54 |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | 3 years |
Raymond Jeffrey Kmetz | M | - | 6 years | |
Robert Tjian | M | 74 | 4 years | |
Hal R. Werner | M | 75 | 8 years | |
Mani Mohindru | M | 52 | 4 years | |
Kenneth Clark | M | 65 | 3 years | |
Roy C. Hardiman | M | 64 | 2 years | |
Paul Schimmel | M | 83 | 5 years | |
Jeffrey Tong | M | 48 | 4 years | |
Avi Z. Naider | M | 52 | 6 years | |
Marianne T. Armstrong | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 3 years |
Steven Harr | M | 53 | 3 years | |
Helen Kim | F | 61 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 9 years |
Eric H. Halvorson | M | 74 | 4 years | |
Myrtle Potter | F | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
Richard B. Love | M | 62 | - | |
Eric Hedrick | M | 59 | 2 years | |
Faheem Hasnain | M | 65 | 6 years | |
Alan Fuhrman | M | 67 | 4 years | |
Franklin Berger | M | 74 | 6 years | |
Sarah Hymowitz | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 22 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 97 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lori Kunkel
- Personal Network